Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€13.53
30.03.20
€29.00
04.11.21
72.28%
05.11.21

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€18.00
21.12.19
€30.00
04.11.21
-36.06%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.29
25.11.19
-
04.11.21
196.12%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€9.43
14.01.21
€28.00
72.92%
12.03.21

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€20.95
10.02.21
€22.00
11.75%
11.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.48
11.01.21
-
11.01.22
39.14%
15.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.90
14.11.20
-
14.11.21
23.24%
27.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€16.60
31.10.20
-
04.11.21
24.82%
09.11.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.92
31.10.20
-
04.11.21
20.56%
09.11.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.27
14.07.20
€5.85
05.08.20
-5.09%
05.08.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.70
24.05.20
€5.00
26.06.20
-0.54%
26.06.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€42.32
29.01.19
€23.00
12.05.20
-66.80%
12.05.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€2.57
18.01.17
€5.00
18.03.20
-26.09%
18.03.20

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€22.73
03.04.19
€27.06
12.03.20
-32.91%
12.03.20

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€10.98
07.10.18
€18.00
31.07.19
-54.69%
31.07.19

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€10.18
25.10.18
€20.80
03.06.19
-41.85%
03.06.19

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.73
16.04.19
€10.00
17.04.19
-6.47%
17.04.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€8.65
15.02.19
€10.00
13.03.19
-2.31%
13.03.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€6.14
24.01.19
€10.00
05.02.19
63.36%
05.02.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.59
11.01.19
€7.00
16.01.19
7.16%
16.01.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.02
28.12.18
€7.00
02.01.19
0.00%
02.01.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected